Roche Valcyte Expected To Erode Ganciclovir Scripts After Spring Launch
Executive Summary
Roche anticipates that Valcyte (valganciclovir) will begin to erode oral Cytovene (ganciclovir) prescriptions for the treatment of cytomegalovirus retinitis in AIDS patients following spring launch.